52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.58.5% up the range
Rs 1,548Rs 2,047
What Sun Pharmaceutical Industries does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary
Grew from a small Gujarat psychiatric-drugs startup into India's largest pharmaceutical company largely through acquisitions, most notably absorbing rival Ranbaxy in 2015 after Ranbaxy's own manufacturing quality scandals. In April 2026 it agreed to buy US-based Organon for 11.75 billion dollars, its largest deal yet, set to nearly double group revenue once it closes.
1
1Sector
Pharmaceuticals - Generics & Specialty
2
2What it sells
Generic and branded generic medicines, active pharmaceutical ingredients, and a growing line of specialty drugs in dermatology, oncology and ophthalmology.
3
3Who buys it
Patients through pharmacies and hospitals across India and over 100 countries; its newer specialty drugs are marketed mainly to US dermatologists, oncologists and ophthalmologists.
4
4How it earns
Earns from high-volume, low-margin generic sales worldwide plus higher-margin specialty drug launches in the US. Profit is sensitive to US generic price erosion, FDA manufacturing-plant compliance at its many facilities, and how fast newly launched specialty medicines gain prescribers.
Implied vs realized volatility
This compares the volatility options are pricing (from the chain) with the volatility the stock has actually delivered. It appears once the live options chain is available.
options live in market hours
The options-implied volatility comes from the live chain, which is available during and around market hours (9:15-3:30 IST, Mon-Fri). The stock has realized 17.8% volatility over the last 30 days; the implied figure and the comparison will show when the chain is live.
SUNPHARMA price vs the biggest options level
The daily candles are the actual stock. The two labeled lines are the single strike with the most call open interest (a resistance level option sellers are defending) and the single strike with the most put open interest (a support level). The full breakdown across every strike is in the Open Interest Profile card below.
EOD 11 Sept
IndicatorsVolume
Loading SUNPHARMA price...
Options snapshot
The live stock option chain (PCR, max pain, expected move, OI) loads during and around market hours.
live in market hours
SUNPHARMA's live option chain - put-call ratio, max pain, expected move and open-interest walls - appears during market hours (9:15-3:30 IST, Mon-Fri). Come back when the market is open for the full options view.
Returns and valuation
Built from the company's own balance sheet and cash flow. Return on equity is the trailing twelve months of profit against the equity on the books; the balance sheet behind it is filed twice a year, not four times.
from the filing as at 2026-03-31
Market cap
Rs 4,41,471 Cr
what the whole company is priced at today
Return on equity
14.4%
profit earned on every Rs 100 of shareholders money
Price to book
5.28x
5.28 times the value on its own books
Return on assets
11.1%
profit against everything it owns
Return on capital
17.9%
EV / EBITDA
22.6x
Dividend yield
0.89%
paid out on today's price
Book value / share
Rs 348
the company's own books, per share
What it owns and what it owes
Straight from the balance sheet in the company's filing. Net debt is borrowings less cash and liquid investments, so a negative figure means it holds more cash than debt.
as at 2026-03-31
Total assets
Rs 1,08,785 Cr
everything the company owns
Shareholders equity
Rs 83,880 Cr
77% of what it owns is funded by its owners
Cash and equivalents
Rs 9,771 Cr
cash and near-cash on hand
Net debt
Rs -26,622 Cr
holds more cash than debt
Debt to equity
0.05x
borrowings against the owners' money
Current ratio
2.82x
short-term assets against short-term dues
Companies file a balance sheet twice a year, not every quarter, so this is the most recent one published rather than the latest quarter.
The cash it actually made
Profit is an accounting figure; cash flow is what moved. Free cash flow is the cash from running the business less what was spent on plant and equipment, so it is what was left over to pay down debt or return to shareholders.
year to 2026-03-31
Cash from operations
Rs 12,419 Cr
cash the business itself threw off
Free cash flow
Rs 8,810 Cr
what was left after spending on the business
FCF margin
15.1%
free cash for every Rs 100 of sales
Cash vs profit
1.08x
every rupee of profit arrived as cash, or more
Cash flow is reported for the year to date, so this covers the full period ending 2026-03-31 rather than a single quarter.
Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.
as of 2026-06-30
P/E (TTM)
36.5
PEG
1.38
EPS (TTM)
Rs 50.4
Net margin
20.2%
Rev growth YoY
+10.46%
Profit growth YoY
+26.53%
TTM revenue
Rs 59,911 Cr
TTM net profit
Rs 12,117 Cr
Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
+10.0%
a year, 3 years
Profit growth
+10.6%
a year, 3 years
Operating margin
30.3%
latest year
Sales by financial yearRs 58,462 Cr
Net profit by financial yearRs 11,509 Cr
FY225 full years · hover a yearFY26
Operating margin has gone from 26.9% to 30.3% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
0.87% yield
Rs 870 / year
Paid 10 of 10 yrs
on Rs 1 lakh at today's price · 0.87% yield · Rs 16/share
What each year paid, on Rs 1 lakh
190
109
149
163
408
543
625
734
870
870
17
18
19
20
21
22
23
24
25
26*
* 2026 so far - more may still be declared this year
2026 has paid Rs 16.00 per share, about Rs 870 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 11 Sept
RSI (14) - momentum
34Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
72%Near average
today 72%20d avg 64.1%
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
vs 50-DMA
-4.62%
vs 200-DMA
+1.94%
1-month
-4.76%
3-month
+2.02%
1-year
+15.46%
Realized vol (30d)
17.8%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months
Insider trading data unavailable.
Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months
Announcements unavailable.
Want to test a strategy on SUNPHARMA?
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.